Neurogene [NGNE] vs Denali Therapeutics [DNLI] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 12 vital metrics comparison: Neurogene wins in 5 metrics, Denali Therapeutics wins in 4 metrics, with 2 ties. Neurogene appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Neurogene Denali Therapeutics Better
P/E Ratio (TTM) N/A -5.65 N/A
Price-to-Book Ratio 0.96 1.80 Neurogene
Debt-to-Equity Ratio 4.01 4.59 Neurogene
PEG Ratio -4.04 -5.07 Denali Therapeutics
EV/EBITDA 0.34 -2.45 Denali Therapeutics
Profit Margin 0.00% 0.00% Tie
Operating Margin -9,701.19% 0.00% Denali Therapeutics
Return on Equity -34.97% -35.21% Neurogene
Return on Assets -21.97% -22.58% Neurogene
Free Cash Flow $-71.41M $-363.61M Neurogene
Dividend Yield 0.00% 0.00% Tie
1-Year Return -43.53% -31.58% Denali Therapeutics
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Neurogene vs Denali Therapeutics Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Neurogene vs Denali Therapeutics Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...